Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|September 14, 2012
Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitisSara N Horst, Sunanda KanePatient Related Outcome Measures|August 24, 2012
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherenceSteven J Bernick, Sunanda KaneClinical and Experimental Gastroenterology|May 30, 2014
Current approaches to the management of new-onset ulcerative colitisRenée Marchioni Beery, Sunanda KaneThe American Journal of Gastroenterology|November 12, 2020
Does Size Really Matter?Nayantara Coelho-Prabhu, Sunanda KaneInflammatory Bowel Diseases|September 28, 2019
Nanotechnology in the Treatment of Inflammatory Bowel DiseaseFanny Giron, Anna Pastó, Ennio Tasciotti, et al.Clinical and Experimental Gastroenterology|November 12, 2024
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to DateKerri Glassner, Christopher Fan, Malcolm Irani, et al.Journal of Clinical Gastroenterology|July 10, 2012
Natural history of pediatric-onset inflammatory bowel disease: a systematic reviewBincy P Abraham, Seema Mehta, Hashem B El-SeragClinical and Experimental Gastroenterology|March 14, 2023
Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported OutcomesMalcolm Irani, Christopher Fan, Kerri Glassner, et al.Nature Clinical Practice. Gastroenterology & Hepatology|March 28, 2008
A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumabAlissa Quin, Sunanda Kane, Olga UlitskyThe American Journal of Gastroenterology|October 19, 2007
Higher incidence of abnormal Pap smears in women with inflammatory bowel diseaseSunanda Kane, Bahar Khatibi, Deepa ReddyPageof 16